Heng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Heng Zhao has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Kepeng Qiu
College of Information Engineering Beijing Institute of Petrochemical Technology Beijing China
1 shared publication- Tiantian Man
Nanjing University of Science and Technology
1 shared publication - Weiwei Wang
College of Information Engineering Beijing Institute of Petrochemical Technology Beijing China
1 shared publication - Xuejun Liu
College of Information Engineering Beijing Institute of Petrochemical Technology Beijing China
1 shared publication
Latest Publications
- 17 June 2026
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 57 (11) , 1885-1900
SERS‐VGG27: A Deep Learning Framework With Two‐Stage Feature Selection for Precise SERS‐Based Drug Classification
Surface‐enhanced Raman spectroscopy (SERS) has become a powerful tool for drug screening; however, its potential is often constrained by complex spectral profiles and the lack of robust analytical tools. Here, we introduce SERS‐VGG27, a deep learning framework that synergizes a two‐stage feature selection with a spectrally optimized neural network architecture to overcome these limitations. This method integrates biomolecule‐guided prescreening with data‐driven refinement, effectively eliminating redundant features while preserving essential biochemical signatures. The refined spectra are then analyzed using the SERS‐VGG27 network—an enhanced architecture derived from VGG19—engineered to reduce the parameter complexity of the feature extraction layers by 21.50% and to sensitively capture subtle, drug‐induced molecular variations. Experimental validation shows that 85.77% of redundant information in the initial SERS dataset is removed during coarse‐grained selection, further reduced to 6.38% after fine‐grained refinement. Leveraging these optimizations, SERS‐VGG27 achieves an accuracy of 96.73% in classifying 21 drug types across eight distinct mechanisms of action, significantly outperforming conventional models. Furthermore, extensive benchmarking across three heterogeneous external datasets—encompassing clinical oncology, toxicology, and microbiology—validates the cross‐domain generalization and reliability of our SERS‐VGG27 framework.
- 17 June 2026
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 57 (11) , 1885-1900
SERS‐VGG27: A Deep Learning Framework With Two‐Stage Feature Selection for Precise SERS‐Based Drug Classification
Surface‐enhanced Raman spectroscopy (SERS) has become a powerful tool for drug screening; however, its potential is often constrained by complex spectral profiles and the lack of robust analytical tools. Here, we introduce SERS‐VGG27, a deep learning framework that synergizes a two‐stage feature selection with a spectrally optimized neural network architecture to overcome these limitations. This method integrates biomolecule‐guided prescreening with data‐driven refinement, effectively eliminating redundant features while preserving essential biochemical signatures. The refined spectra are then analyzed using the SERS‐VGG27 network—an enhanced architecture derived from VGG19—engineered to reduce the parameter complexity of the feature extraction layers by 21.50% and to sensitively capture subtle, drug‐induced molecular variations. Experimental validation shows that 85.77% of redundant information in the initial SERS dataset is removed during coarse‐grained selection, further reduced to 6.38% after fine‐grained refinement. Leveraging these optimizations, SERS‐VGG27 achieves an accuracy of 96.73% in classifying 21 drug types across eight distinct mechanisms of action, significantly outperforming conventional models. Furthermore, extensive benchmarking across three heterogeneous external datasets—encompassing clinical oncology, toxicology, and microbiology—validates the cross‐domain generalization and reliability of our SERS‐VGG27 framework.